The optimal intensity of oral anticoagulation therapy in patients with prosthetic heart valves

Suzanne C. Cannegieter; Frits R. Rosendaal; E. Briët

doi:10.1016/0049-3848(92)90474-o

Related publications

Article1994

31P Optimal intensity of long-term oral anticoagulant therapy in 3404 post-myocardial infarction patients

Aïda J. Azar, Jaap W. Deckers, Frits R. Rosendaal, E. Briët

Controlled Clinical Trials

Article2020

Determinants of low‐quality warfarin anticoagulation in patients with mechanical prosthetic heart valves. The nationwide PLECTRUM study

Daniele Pastori, Professor Gregory Lip, Daniela Poli, Emilia Antonucci, Luca Rubino, Danilo Menichelli, Mirella Saliola, Francesco Violi, Gualtiero Palareti, Pasquale Pignatelli

Article2025

TCTAP A-001 Patients With a Small Annulus in the LANDMARK Trial - Early Outcomes With Three TAVI Valves

Patrick W. Serruys, Akihiro Tobe, Niels van Royen, Ignacio J. Amat‐Santos, Martin Hudec, Matjaž Bunc, Alexander Ijsselmuiden, Peep Laanmets, Daniel Unić, Béla Merkely, Renicus S. Hermanides, Vlasis Ninios, Marcin Protasiewicz, Benno Rensing, Pedro Martín, Fausto Feres, Manuel Almeida, Éric Van Belle, Axel Linke, Alfonso Ielasi, Matteo Montorfano, Mark Webster, Konstantinos Toutouzas,

Article1984

Haemodynamic effects of intravenous cibenzoline in patients with coronary heart disease

Marcel van den Brand, Patrick W. Serruys, Y. de Roon, Marie France Aymard, A Dufour

European Journal of Clinical Pharmacology

Article2009

Optimal revascularization strategies in patients with total occlusions: 1-year results from the syntax trial

Patrick W. Serruys, Jacques Koolen, Ted Feldman, Michael J. Mack, Elisabeth Ståhle, David R. Holmes, A. Pieter Kappetein, Marie‐Claude Morice, Antonio Colombo, Katrin Leadley, Keith D. Dawkins, Friedrich W. Mohr

Cardiovascular revascularization medicine